These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 9120931

  • 1. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.
    Witherspoon LR, Lapeyrolerie T.
    J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931
    [Abstract] [Full Text] [Related]

  • 2. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
    Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.
    J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796
    [Abstract] [Full Text] [Related]

  • 3. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
    Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG.
    Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [Abstract] [Full Text] [Related]

  • 5. Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy.
    Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H.
    J Urol; 1999 Apr 15; 161(4):1206-11. PubMed ID: 10081870
    [Abstract] [Full Text] [Related]

  • 6. Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.
    Shen S, Lepor H, Yaffee R, Taneja SS.
    J Urol; 2005 Mar 15; 173(3):777-80. PubMed ID: 15711268
    [Abstract] [Full Text] [Related]

  • 7. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.
    Yu H, Diamandis EP, Wong PY, Nam R, Trachtenberg J.
    J Urol; 1997 Mar 15; 157(3):913-8. PubMed ID: 9072598
    [Abstract] [Full Text] [Related]

  • 8. Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database.
    Chang SL, Freedland SJ, Terris MK, Aronson WJ, Kane CJ, Amling CL, Presti JC.
    Urology; 2010 Feb 15; 75(2):439-44. PubMed ID: 19819536
    [Abstract] [Full Text] [Related]

  • 9. The periurethral glands do not significantly influence the serum prostate specific antigen concentration.
    Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Yemoto C, Stamey TA.
    J Urol; 1996 May 15; 155(5):1658-60. PubMed ID: 8627847
    [Abstract] [Full Text] [Related]

  • 10. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.
    J Urol; 2003 Feb 15; 169(2):517-23. PubMed ID: 12544300
    [Abstract] [Full Text] [Related]

  • 11. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
    Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC.
    J Urol; 1999 Oct 15; 162(4):1337-40. PubMed ID: 10492192
    [Abstract] [Full Text] [Related]

  • 12. Use of serum concentration techniques to enhance early detection of recurrent prostate cancer after radical prostatectomy.
    Pruthi RS, Haese A, Huland E, Stamey TA.
    Urology; 1997 Mar 15; 49(3):404-10. PubMed ID: 9123706
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
    Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.
    Urology; 2004 Oct 15; 64(4):723-8. PubMed ID: 15491709
    [Abstract] [Full Text] [Related]

  • 15. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH.
    Eur Urol; 2005 Dec 15; 48(6):906-10. PubMed ID: 16126322
    [Abstract] [Full Text] [Related]

  • 16. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC.
    Cancer; 2007 Apr 01; 109(7):1273-8. PubMed ID: 17315165
    [Abstract] [Full Text] [Related]

  • 17. [PSA and follow-up after treatment of prostate cancer].
    Benchikh El Fegoun A, Villers A, Moreau JL, Richaud P, Rebillard X, Beuzeboc P.
    Prog Urol; 2008 Mar 01; 18(3):137-44. PubMed ID: 18472065
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The value of PSA follow-up in recurrent prostate carcinoma after radical prostatovesiculectomy].
    Trinkler F, Hauri D.
    Helv Chir Acta; 1994 Dec 01; 60(6):1081-5. PubMed ID: 7533147
    [Abstract] [Full Text] [Related]

  • 20. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.